BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15132175)

  • 1. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
    Bayomi MA
    Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of polymers weight ratio and pH of polymers solution on the characteristics of chitosan-carboxymethyl cellulose microspheres containing theophylline.
    Bayomi MA
    Boll Chim Farm; 2003 Oct; 142(8):336-42. PubMed ID: 15040463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin loaded chitosan microspheres. Correlation between the erosion process and release kinetics.
    Orienti I; Aiedeh K; Gianasi E; Bertasi V; Zecchi V
    J Microencapsul; 1996; 13(4):463-72. PubMed ID: 8808782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique.
    Bayomi MA; al-Suwayeh SA; el-Helw AM; Mesnad AF
    Pharm Acta Helv; 1998 Dec; 73(4):187-92. PubMed ID: 9861867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
    Thanoo BC; Sunny MC; Jayakrishnan A
    J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan microspheres prepared by an aqueous process: release of indomethacin.
    Aggarwal A; Kaur S; Tiwary AK; Gupta S
    J Microencapsul; 2001; 18(6):819-23. PubMed ID: 11695644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
    Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan microspheres prepared by spray drying.
    He P; Davis SS; Illum L
    Int J Pharm; 1999 Sep; 187(1):53-65. PubMed ID: 10502613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method.
    Pavanetto F; Perugini P; Conti B; Modena T; Genta I
    J Microencapsul; 1996; 13(6):679-88. PubMed ID: 8933353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation variables on cis-platin loaded chitosan microsphere properties.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1999; 16(6):697-703. PubMed ID: 10575622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
    Sankar C; Mishra B
    Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
    Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method.
    Lin WJ; Kang WW
    J Microencapsul; 2003; 20(2):169-77. PubMed ID: 12554372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent.
    Kumbar SG; Kulkarni AR; Aminabhavi M
    J Microencapsul; 2002; 19(2):173-80. PubMed ID: 11837972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.